Exploring the Design, Synthesis, and Comprehensive Biological Evaluation of Novel Imidazo[1‐b][1,3,4]thiadiazole Derivatives for Potential Therapeutic Applications

Abstract

In order to manufacture imidazo[1‐b][1,3,4]thiadiazole, the beginning components that are used are the 2,4-dinitro benzoic acid and the thiosemicarbazide. The synthesis of the corresponding imidazolthadiazole derivative was brought about as a consequence of their interaction with phenacyl bromides, which are also referred to as p-substituted phenacyl bromides. The structure of these compounds was validated